Immunotherapy drug may extend cancer-free time after head and neck cancer relapse
Disease control
Ongoing
This study tests whether the immunotherapy drug pembrolizumab, given after salvage surgery, can help keep head and neck cancer from returning in people whose cancer has come back locally. About 27 adults with confirmed squamous cell carcinoma of the head and neck are participatin…
Phase: PHASE2 • Sponsor: Assuntina G. Sacco, MD • Aim: Disease control
Last updated May 17, 2026 07:27 UTC